Sana Biotechnology

About:

Sana Biotechnology is a developer of engineered cells intended to be used as medicine for patients.

Website: http://sana.com/

Top Investors: F-Prime Capital, ARCH Venture Partners, Google Ventures, CPP Investments, Alaska Permanent Fund

Description:

Sana Biotechnology focuses on creating and delivering engineered cells as medicine for patients. Recent scientific advances make it possible to reprogram cells in the body or replace damaged cells and tissues, creating a new class of medicines to treat a broad array of diseases. The company is a team of scientists, clinicians and biotechnology veterans focused on creating an enduring company that makes meaningful medicines and will change the approach in treating diseases.

Total Funding Amount:

$865M

Headquarters Location:

Seattle, Washington, United States

Founded Date:

2018-01-01

Contact Email:

contact(AT)sana.com

Hub Tags:

Exited Unicorn

Founders:

Geoffrey von Maltzahn, Jack Milwid, Jacob Rubens, Michael Mee, Sonja Schrepfer, Steve Harr

Number of Employees:

251-500

Last Funding Date:

2024-02-08

IPO Status:

Public

© 2025 bioDAO.ai